CID 159554

14-salicyloylcarubicin

Structural Information

Molecular Formula
C33H31NO13
SMILES
CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)O)O)(C(=O)COC(=O)C6=CC=CC=C6O)O)N)O
InChI
InChI=1S/C33H31NO13/c1-13-27(38)17(34)9-22(46-13)47-20-11-33(44,21(37)12-45-32(43)14-5-2-3-7-18(14)35)10-16-24(20)31(42)26-25(29(16)40)28(39)15-6-4-8-19(36)23(15)30(26)41/h2-8,13,17,20,22,27,35-36,38,40,42,44H,9-12,34H2,1H3
InChIKey
AJAHDRMPRTTZMX-UHFFFAOYSA-N
Compound name
[2-[4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]-2-oxoethyl] 2-hydroxybenzoate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

649.17957 Da
Monoisotopic Mass

2.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 650.18685 242.8
[M+Na]+ 672.16879 247.9
[M-H]- 648.17229 240.6
[M+NH4]+ 667.21339 245.0
[M+K]+ 688.14273 240.4
[M+H-H2O]+ 632.17683 230.0
[M+HCOO]- 694.17777 246.8
[M+CH3COO]- 708.19342 250.7
[M+Na-2H]- 670.15424 266.2
[M]+ 649.17902 260.2
[M]- 649.18012 260.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.